Table of Content - Urinary Incontinence Treatment Drugs Market

Urinary incontinence is considered to be the variety of abnormalities occurs in the urinary tract that results in to experiencing normal micturition. This leads to involuntary loss of bladder control. Approximately 40% of community-dwelling elderly and hospitalized patients are afflicted with this disorder and the remaining 60% of nursing home patients experience this disorder, and it is often the reason for their admittance. The causes of urinary incontinence are numerous and involves age-related changes in the bladder and urethra, including decline in outlet resistance in females and prostate enlargement in males.

In urinary incontinence, muscles around urethra do not work in the way they should, resulting in leak-out of urine. There are various types of incontinences such as stress (bladder is under pressure), urge (intense urge to pass urine), and overflow (chronic urinary retention). The severity of urinary incontinence varies as per health conditions such as urinary tract infection (UTI), constipation, and age group, as urinary incontinence is found more in geriatric population.

Market Dynamics

The urinary incontinence treatment drugs market is expected to drive the market growth during the forecast period, owing to increasing prevalence of urinary incontinence disease. For instance, according to American Urological Association (AUA) 2017 report, more than 200 million people worldwide were affected with stress urinary incontinence (SUI) in 2017, which can seriously affect the quality of life of both men and women. As a disease whose prevalence is related to advancing age, it affects more women than men with an approximate ratio of 3: 1.

Key features of the study:

This report provides in-depth analysis of the global urinary incontinence treatment drugs market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global urinary incontinence treatment drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Johnson & Johnson, Pfizer Inc., Astellas Pharma, Inc., Allergan, Inc., Takeda Pharmaceutical Company Limited, Merck & Co., Inc., and Sanofi S.A.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global urinary incontinence treatment drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the urinary incontinence treatment drugs market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Urinary Incontinence Treatment Drugs Market, By Incontinence Type:
- Urge Incontinence
- Stress Incontinence
- Over-flow Incontinence
- Mixed Incontinence
- Other Type
Global Urinary Incontinence Treatment Drugs Market, By Drug Class:
- Anticholinergic/Antispasmodic Agents
- Skeletal Muscle Relaxants
- Antidepressants
- Alpha Blockers
- Topical Estrogens
- Others
Global Urinary Incontinence Treatment Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Urinary Incontinence Treatment Drugs Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
  - By Incontinence Type:
    - Urge Incontinence
    - Stress Incontinence
    - Over-flow Incontinence
    - Mixed Incontinence
    - Other Type
  - By Drug Class:
    - Anticholinergic/Antispasmodic Agents
    - Skeletal Muscle Relaxants
    - Antidepressants
    - Alpha Blockers
    - Topical Estrogens
    - Others
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
- Europe
  - By Country:
    - U.K.
    - Germany
    - Italy
    - Spain
    - France
    - Russia
    - Rest of Europe
  - By Incontinence Type:
    - Urge Incontinence
    - Stress Incontinence
    - Over-flow Incontinence
    - Mixed Incontinence
    - Other Type
  - By Drug Class:
    - Anticholinergic/Antispasmodic Agents
    - Skeletal Muscle Relaxants
    - Antidepressants
    - ALPHA Blockers
    - Topical Estrogens
    - Others
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
- Asia Pacific
  - By Country:
    - Australia
    - India
    - China
    - Japan
    - ASEAN
    - South Korea
    - Rest of Asia Pacific
  - By Incontinence Type:
    - Urge Incontinence
    - Stress Incontinence
    - Over-flow Incontinence
    - Mixed Incontinence
    - Other Type
  - By Drug Class:
    - Anticholinergic/Antispasmodic Agents
    - Skeletal Muscle Relaxants
    - Antidepressants
    - Alpha Blockers
    - Topical Estrogens
    - Others
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
  - By Incontinence Type:
    - Urge Incontinence
    - Stress Incontinence
    - Over-flow Incontinence
    - Mixed Incontinence
    - Other Type
  - By Drug Class:
    - Anticholinergic/Antispasmodic Agents
    - Skeletal Muscle Relaxants
    - Antidepressants
    - Alpha Blockers
    - Topical Estrogens
    - Others
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
  - By Incontinence Type:
    - Urge Incontinence
    - Stress Incontinence
    - Over-flow Incontinence
    - Mixed Incontinence
    - Other Type
  - By Drug Class:
    - Anticholinergic/Antispasmodic Agents
    - Skeletal Muscle Relaxants
    - Antidepressants
    - Alpha Blockers
    - Topical Estrogens
    - Others
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
  - By Incontinence Type:
    - Urge Incontinence
    - Stress Incontinence
    - Over-flow Incontinence
    - Mixed Incontinence
    - Other Type
  - By Drug Class:
    - Anticholinergic/Antispasmodic Agents
    - Skeletal Muscle Relaxants
    - Antidepressants
    - Alpha Blockers
    - Topical Estrogens
    - Others
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
Company Profiles
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Pfizer Inc.
- Astellas Pharma, Inc.
- Allergan, Inc.
- Takeda Pharmaceutical Company Limited
- Merck & Co., Inc.
- Sanofi S.A.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Incontinence Type
  - Market Snippet, By Drug Class
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Recent Trends
- Recent Launches/Approvals
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’s Analysis
Global Urinary Incontinence Treatment Drugs Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Urinary Incontinence Treatment Drugs Market, By Incontinence Type, 2018– 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Urge Incontinence
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Stress Incontinence
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Over-flow Incontinence
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Mixed Incontinence
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Other Incontinence Type
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
Global Urinary Incontinence Treatment Drugs Market, By Drug Class, 2018 – 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Anticholinergic/Antispasmodic Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Skeletal Muscle Relaxants
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Antidepressants
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Alpha Blockers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Topical Estrogens
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  - Segment Trends
Global Urinary Incontinence Treatment Drugs Market, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Global Urinary Incontinence Treatment Drugs Market, By Region, 2018 – 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Incontinence Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Incontinence Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Incontinence Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Incontinence Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Incontinence Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Incontinence Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 –2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Johnson & Johnson
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Astellas Pharma, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Allergan, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Merck & Co., Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sanofi S.A.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - IXALTIS
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Bayer AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - elicept Therapeutics
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Taiho Pharmaceutical
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Cook MyoSite
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Urovant Sciences GmbH
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Analysts’ Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 36 market data tables and 26 figures on “Global Urinary Incontinence Treatment Drugs Market” – Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount